Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
TELA Bio, Inc. - Common stock
(NQ:
TELA
)
0.9050
-0.0850 (-8.59%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about TELA Bio, Inc. - Common stock
< Previous
1
2
3
4
5
6
7
Next >
TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy
April 08, 2024
Howard N. Langstein, MD, FACS joins innovative MedTech company to leverage his vast experience to help other surgeons optimize clinical outcomes in plastic and reconstructive surgery
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Stock Earnings: TELA Bio Misses EPS, Beats Revenue for Q4 2023
↗
March 21, 2024
TELA stock results show that TELA Bio missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Recap: TELA Bio Q4 Earnings
↗
March 21, 2024
Via
Benzinga
TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery
March 21, 2024
Strong and secure, LIQUIFIX is the first approved adhesive-based product to affix mesh without penetrating patient tissue
From
TELA Bio, Inc.
Via
GlobeNewswire
Preview: TELA Bio's Earnings
↗
March 20, 2024
Via
Benzinga
Earnings Scheduled For March 21, 2024
↗
March 21, 2024
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million.
Via
Benzinga
TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX
March 20, 2024
TELA Bio to receive at least $8 million and up to $12 million in total consideration
From
TELA Bio, Inc.
Via
GlobeNewswire
Recap: TELA Bio Q3 Earnings
↗
November 09, 2023
Via
Benzinga
Recap: TELA Bio Q1 Earnings
↗
May 11, 2023
Via
Benzinga
TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results
February 29, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 23, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 19, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 15, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Take Part in Connecting the Dots
December 05, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Participate in Piper Sandler’s 35th Annual Healthcare Conference
November 16, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 10, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
November 09, 2023
Via
Benzinga
TELA Bio Reports Third Quarter 2023 Financial Results
November 09, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Announce Third Quarter 2023 Financial Results
October 26, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Earnings Scheduled For November 9, 2023
↗
November 09, 2023
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million.
Via
Benzinga
TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase
September 18, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces U.S. Commercial Launch of OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery
August 16, 2023
New addition expands reconstruction options for surgeons and patients
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Reports Second Quarter 2023 Financial Results
August 09, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 04, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Announce Second Quarter 2023 Financial Results and Confirms Participation in the Canaccord Genuity 43rd Annual Growth Conference
July 26, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Participate in the Jefferies Global Healthcare Conference
May 25, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Invests in Surgeon Training and Education with Upcoming Cadaver Lab
May 19, 2023
Company prioritizes education with a variety of in-person and virtual training programs
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Reports First Quarter 2023 Financial Results
May 11, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Earnings Scheduled For May 11, 2023
↗
May 11, 2023
Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its...
Via
Benzinga
TELA Bio Supports Diversity and Inclusion at International Hernia Collaboration Conference
May 09, 2023
Leader in innovative soft-tissue tissue reconstruction solutions sponsors event advocating for and mentoring women in surgery
From
TELA Bio, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
